In addition, most of the cases without recurrent genetic abnormalities (including AML with MDS related changes, NOS and therapy-related cases) showed a similar phenotype, usually CD34+ CD38lo, which has been related to an immature phenotype and properties of leukemic stem cells [30,31,32]. This evidence concerns the gene CD34 and myelodysplastic syndrome.